V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20221524 | 20084266 | null | 76.8 | Palliative (P) | 2016-09-12 | 2016-09-13 | Enzalutamide | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101211607 |
| 20221531 | 20084267 | 1.61 | 79 | Palliative (P) | 2019-11-27 | 2019-12-14 | LUTETIUM-177 | 02 | N | LUTETIUM-177 | 100551948 |
| 20221533 | 20084268 | 1.7 | 67.6 | Palliative (P) | 2018-12-10 | 2018-12-10 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 02 | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 101233092 |
| 20221539 | 20084269 | 1.81 | 62.1 | Neo-adjuvant (N) | 2017-07-18 | 2017-07-30 | Enzalutamide | 02 | N | CISPLATIN | 101593640 |
| 20221545 | 20084270 | 1.7 | 88.6 | null | 2016-03-31 | 2016-04-11 | Enzalutamide | 02 | null | SCALOP-2 TRIAL | 100963256 |
| 20221549 | 20084271 | 1.67 | 91 | Neo-adjuvant (N) | 2019-01-05 | 2019-01-19 | GemCarbo Days 1+8 | 02 | N | CARBOPLATIN + GEMCITABINE | 101701201 |
| 20221552 | 20084272 | 1.57 | 56.9 | Palliative (P) | 2019-01-28 | 2019-02-15 | Capecitabine + Cisplatin + RT | N | N | CAPECITABINE + CISPLATIN + RT | 101528589 |
| 20221557 | 20084273 | 1.59 | 72 | null | 2016-02-25 | 2016-02-26 | Enzalutamide | 02 | N | MITOMYCIN INTRAVESICULAR | 100470260 |
| 20221578 | 20084274 | 1.71 | 82.9 | Adjuvant (A) | 2019-02-19 | 2019-02-19 | TRASTUZUMAB | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101207105 |
| 20221582 | 20084275 | 1.61 | 74.1 | Palliative (P) | 2017-12-11 | 2018-01-09 | Enzalutamide | 1 | N | CISPLATIN | 101678723 |
| 20221588 | 20084276 | 1.64 | 76 | Palliative (P) | 2016-04-04 | 2016-04-28 | CARBOPLATIN | 02 | N | CARBOPLATIN | 100099338 |
| 20221603 | 20084277 | null | 85.7 | null | 2018-04-21 | 2018-05-11 | CAPECITABINE + CISPLATIN + EPIRUBICIN | 02 | null | CAPECITABINE + CISPLATIN + EPIRUBICIN | 101764788 |
| 20221621 | 20084278 | 1.7 | 64 | Palliative (P) | 2016-04-10 | 2016-05-07 | OCTREOTIDE | 02 | N | OCTREOTIDE | 100600728 |
| 20221622 | 20084279 | 1.7 | 73.6 | Palliative (P) | 2015-02-16 | 2015-03-03 | Enzalutamide | 02 | N | ATEZOLIZUMAB + BEVACIZUMAB | 100142899 |
| 20221627 | 20084280 | 0 | 83.6 | 03 | 2017-02-01 | 2017-02-01 | LUTETIUM-177 | 02 | N | LUTETIUM-177 | 100432064 |
| 20221628 | 20084281 | 1.75 | null | Curative (C) | 2013-03-07 | 2017-08-29 | Enzalutamide | 02 | Y | CAPECITABINE + CISPLATIN + EPIRUBICIN | 101422298 |
| 20221629 | 20084282 | 1.6 | 50.1 | null | 2016-04-11 | 2016-04-11 | Capecitabine + Cisplatin + RT | 02 | null | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101793639 |
| 20221631 | 20084283 | 1.6 | 58 | Palliative (P) | 2018-05-08 | 2018-05-15 | Enzalutamide | 02 | N | CARBOPLATIN | 101216516 |
| 20221633 | 20084284 | 1.53 | 55.7 | Curative (C) | 2016-08-31 | 2016-09-20 | Enzalutamide | 02 | null | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100176191 |
| 20221634 | 20084285 | 1.66 | 45 | 03 | null | 2016-04-18 | Mitomycin Intravesical | 02 | N | MITOMYCIN INTRAVESICULAR | 100725376 |
| 20221639 | 20084286 | 0 | 0 | Palliative (P) | 2018-12-02 | 2018-12-02 | Enzalutamide | 2 | Y | SCALOP-2 TRIAL | 101598419 |
| 20221640 | 20084287 | 1.78 | 105 | Palliative (P) | 2016-03-24 | 2016-03-29 | Enzalutamide | 02 | N | ATEZOLIZUMAB + BEVACIZUMAB | 100713091 |
| 20221647 | 20084288 | 1.62 | 63.4 | Curative (C) | 2015-07-30 | 2015-07-30 | Enzalutamide | N | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 101777110 |
| 20221648 | 20084289 | 1.7 | 64 | Palliative (P) | 2018-06-03 | 2018-06-05 | CARBOPLATIN + GEMCITABINE | 02 | N | CARBOPLATIN + GEMCITABINE | 101440335 |
| 20221655 | 20084290 | 1.77 | null | Neo-adjuvant (N) | 2011-09-10 | 2017-05-12 | Enzalutamide | 02 | Y | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100121592 |
| 20221657 | 20084291 | 1.56 | 67.2 | Curative (C) | 2019-05-09 | 2019-05-09 | Enzalutamide | 02 | N | CAPECITABINE + TEMOZOLOMIDE | 101042109 |
| 20221667 | 20084292 | 1.64 | 58 | Curative (C) | 2017-10-18 | 2017-10-19 | Capecitabine + Cisplatin + RT | 2 | N | OCTREOTIDE | 101850605 |
| 20221679 | 20084293 | 1.6 | 61.7 | Palliative (P) | 2018-02-16 | 2018-02-26 | Enzalutamide | 02 | N | ENZALUTAMIDE | 101396078 |
| 20221691 | 20084294 | 1.6 | 54.7 | 03 | 2018-07-11 | 2018-07-13 | Enzalutamide | 02 | N | CETUXIMAB | 100460507 |
| 20221697 | 20084295 | 1.57 | 69.7 | 03 | 2018-05-15 | 2018-05-15 | Enzalutamide | 02 | N | CETUXIMAB + OXALIPLATIN + MDG | 100195793 |
| 20221699 | 20084296 | 1.54 | 112.4 | Palliative (P) | 2019-06-28 | 2019-07-08 | Capecitabine + Cisplatin + RT | 02 | N | CAPECITABINE + CISPLATIN + RT | 101243609 |
| 20221708 | 20084297 | 1.69 | 64.2 | Curative (C) | 2018-11-17 | 2018-11-23 | CARBOPLATIN + PACLITAXEL + RT | 2 | N | CARBOPLATIN + PACLITAXEL + RT | 100897659 |
| 20221710 | 20084298 | 1.51 | 76 | Neo-adjuvant (N) | 2019-12-07 | 2019-12-17 | CARBOPLATIN + PACLITAXEL + RT | 02 | N | CARBOPLATIN + PACLITAXEL + RT | 101235390 |
| 20221711 | 20084299 | null | null | Palliative (P) | 2017-12-20 | 2017-12-23 | Enzalutamide | 02 | N | CAPECITABINE + TEMOZOLOMIDE | 100034054 |
| 20221713 | 20084300 | 1.83 | 64.1 | null | 2018-06-16 | 2018-06-26 | Capecitabine + Cisplatin + RT | 02 | null | CARBOPLATIN | 100830799 |
| 20221714 | 20084301 | 1.5 | 88 | Palliative (P) | 2018-02-10 | 2018-02-14 | Enzalutamide | 02 | N | ECF | 101406570 |
| 20221722 | 20084302 | 1.77 | 39.8 | Neo-adjuvant (N) | 2018-02-08 | 2018-02-08 | Capecitabine + Cisplatin + RT | 02 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100316481 |
| 20221724 | 20084303 | 1.9 | 95.1 | Palliative (P) | 2018-01-24 | 2018-01-24 | Enzalutamide | N | N | CARBOPLATIN | 100998093 |
| 20221726 | 20084304 | 1.6 | 57 | Palliative (P) | 2019-01-25 | 2019-01-30 | Enzalutamide | 02 | N | ECF | 100945956 |
| 20221727 | 20084305 | 1.57 | null | Neo-adjuvant (N) | 2016-08-14 | 2016-08-19 | Enzalutamide | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101508167 |
| 20221730 | 20084306 | 0 | 82.5 | Curative (C) | 2018-07-12 | 2018-07-19 | Enzalutamide | 02 | Y | TRASTUZUMAB | 100297686 |
| 20221737 | 20084307 | 1.72 | 85.7 | Adjuvant (A) | 2018-05-23 | 2018-05-23 | Enzalutamide | 02 | N | OXALIPLATIN + RALTITREXED | 101740556 |
| 20221738 | 20084308 | 1.73 | 96 | 03 | 2017-05-06 | 2017-05-06 | Enzalutamide | null | N | CETUXIMAB | 101212264 |
| 20221741 | 20084309 | 1.65 | 70.7 | Curative (C) | 2019-03-07 | 2019-03-14 | Enzalutamide | 2 | N | CISPLATIN | 101125014 |
| 20221754 | 20084310 | 0 | 0 | Palliative (P) | null | 2019-02-24 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 100609883 |
| 20221759 | 20084311 | 1.78 | 75.2 | Palliative (P) | 2018-07-23 | 2018-07-23 | Enzalutamide | null | N | OXALIPLATIN + RALTITREXED | 100398377 |
| 20221760 | 20084312 | 0 | 55.2 | Palliative (P) | 2017-10-16 | 2017-10-23 | Capecitabine + Cisplatin + RT | 02 | N | CAPECITABINE + CISPLATIN + RT | 100204272 |
| 20221765 | 20084313 | 1.57 | 105 | Palliative (P) | 2019-10-15 | 2019-10-15 | Enzalutamide | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101791194 |
| 20221777 | 20084314 | 1.7 | 60.4 | 03 | 2016-07-18 | 2016-07-31 | GemCarbo Days 1+8 | 02 | N | CARBOPLATIN + GEMCITABINE | 100450684 |
| 20221781 | 20084315 | 1.7 | 107 | null | 2016-02-20 | 2016-02-22 | Enzalutamide | N | null | CARBOPLATIN | 101361146 |